Russia to sell 100 million doses of COVID-19 vaccine to India

Deal comes as India's coronavirus cases surged past 5 million on Wednesday

Russia to sell 100 million doses of COVID-19 vaccine to India

Photo for representational purpose only.

Moscow, September 16

Russia's sovereign wealth fund has agreed to supply 100 million doses of its coronavirus vaccine, Sputnik-V, to Indian drug company Dr Reddy's Laboratories, the fund said on Wednesday, as Moscow speeds up plans to distribute its shot abroad.

The deal comes after the Russian Direct Investment Fund (RDIF) reached agreements with Indian manufacturers to produce 300 million doses of the vaccine in India, which is a major consumer of Russian oil and arms.

Dr Reddy's, one of India's top pharmaceutical companies, will carry out Phase III clinical trials of the vaccine in India, pending regulatory approval, RDIF said in a statement.

Deliveries to India could begin in late 2020, it said, adding this was subject to the completion of trials and the vaccine's registration by regulatory authorities in India.

Russia was the first country to license a novel coronavirus vaccine before large-scale Phase III trials were complete, stirring concern among scientists and doctors about the safety and efficacy of the shot.

The Phase I and II results had shown promise, G V Prasad, co-chairman of Dr Reddy's, was cited in the RDIF statement as saying.

"Sputnik V vaccine could provide a credible option in our fight against COVID-19 in India," he said.

There was no detail about the price of the vaccine but RDIF has said previously it was not aiming at making a profit, just covering costs.

The agreement comes as India's coronavirus cases surged past 5 million on Wednesday, piling pressure on hospitals grappling with unreliable supplies of oxygen that they need to treat tens of thousands of critical patients.

India is only the second country in the world to cross the grim milestone and said this week it is considering granting an emergency authorisation for a vaccine, particularly for the elderly and people in high-risk workplaces.

The RDIF has already reached vaccine supply deals with Kazakhstan, Brazil and Mexico. It has also signed a memorandum with the Saudi Chemical company.

Russia has billed Sputnik-V as the first vaccine against the coronavirus to be registered in the world. Phase III trials, involving at least 40,000 people, were launched in Russia on Aug. 26 but have yet to be completed. Reuters

Top Stories

India, US to ink landmark defence pact on Tuesday, say officials

India, US to ink landmark defence pact on Tuesday, say officials

US Secretary of State Mike Pompeo, Defence Secretary Mark Es...

Three PDP leaders resign over Mehbooba Mufti’s flag remark

Three PDP leaders resign over Mehbooba Mufti’s flag remark

Say feeling 'uncomfortable' over some of her actions and utt...

Stubble-burning: SC keeps in abeyance its order appointing Justice Lokur panel

Stubble-burning: SC keeps in abeyance its order appointing Justice Lokur panel

Solicitor General Tushar Mehta tells a Bench led by CJI SA B...

21-year-old girl student shot dead outside Faridabad college

21-year-old girl student shot dead outside Faridabad college

One youth was known to the victim and a complaint of molesta...

PGI to resume OPD services from November 2

PGI to resume OPD services from November 2

A fixed number of 50 patients will be seen in each OPD; walk...

Cities

View All